IL6 and Sezary syndrome: The present study showed that patients with Sheehan syndrome who are receivingconventional hormone replacement without GH exhibit a clustering of adversecardiovascular risk factors, i.e., an atherogenic lipid profile,elevated levels of the inflammatory markers TNF-α and IL-6, and increasedCIMT values compared with healthy controls.